All In Biotech

Free tool

FAERS Monitor: Pomalyst

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 204026 or its brand name (Pomalyst, Pomalidomide). Reports on generic versions are filed under their own applications.

Reports

103,640

Serious

63,661

61% of reports

Hospitalization

27,668

Death reported

14,174

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • plasma cell myeloma8,169
  • death7,797
  • fatigue7,599
  • pneumonia6,387
  • off label use4,625
  • diarrhoea3,966
  • white blood cell count decreased3,709
  • neutropenia3,391
  • rash3,107
  • dyspnoea2,887
  • asthenia2,718
  • constipation2,705
  • neuropathy peripheral2,694
  • nausea2,603
  • product dose omission issue2,338

Reports by year received

View as table
YearReports
20112
20126
20131,217
20142,659
20155,383
20165,867
20176,831
20187,077
20199,195
202010,066
202113,133
202211,306
20238,275
20248,960
20258,607
20265,056

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,950,519 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
plasma cell myelomaSignal8,16953.552.2333,181
white blood cell count decreasedSignal3,7097.26.919,057
neuropathy peripheralSignal2,6945.95.710,660
neutropeniaSignal3,3915.25.011,174
pneumoniaSignal6,3874.14.014,686
constipationSignal2,7052.52.42,510
fatigue7,5992.01.93,850
death7,7971.81.83,113
product dose omission issue2,3381.61.6555
asthenia2,7181.51.4413
rash3,1071.41.4439
diarrhoea3,9661.21.2201
off label use4,6251.11.023
dyspnoea2,8871.01.03
nausea2,6030.70.6450

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.